Filing
3rd Quarter - Report
Bills named in this filing
1
Lobbying activity
1
Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; The Special Diabetes Program Reauthorization Act (H.R. 2550); FDA guidance on diabetes endpoints; Policy related to the use of Continuous Glucose Monitors; The Centers for Medicare and Medicaid Services (CMS) competitive bidding proposal.